Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: Results from BMTCTN 0201

Journal of Clinical Oncology

Volumn 32, Issue 22, 2014, Pages 2365-2372

  Waller, Edmund K ^a   Logan, Brent R ^b   Harris, Wayne A C ^a   Devine, Steven M ^c   Porter, David L ^d   Mineishi, Shin ^e   McCarty, John M ^f   Gonzalez, Corina E ^g   Spitzer, Thomas R ^h   Krijanovski, Oleg I ⁱ   Linenberger, Michael L ^j   Woolfrey, Ann ^j   Howard, Alan ^k   Wu, Juan ^l   Confer, Dennis L ^k   Anasetti, Claudio ^m  

^a EMORY CLINIC   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Sutter East Bay Medical Foundation   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k NATIONAL MARROW DONOR PROGRAM   (United States)

^l EMMES CORPORATION   (United States)

^m H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; INFANT; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID METAPLASIA; NORTH AMERICA; OVERALL SURVIVAL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UNRELATED DONORS;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; PRIMARY MYELOFIBROSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; T-LYMPHOCYTES; UNRELATED DONORS; YOUNG ADULT;

EID: 84905828126     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.4577     Document Type: Article

References (31)

1. Anderson BE, McNiff JM, Jain D, et al: Distinct roles for donor- and host-derived antigenpresenting cells and costimulatory molecules in murine chronic graft-versus-host disease: Requirements depend on target organ. Blood 105:2227-2234, 2005 (Pubitemid 40731817)
2. Duffner UA, Maeda Y, Cooke KR, et al: Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 172:7393-7398, 2004 (Pubitemid 38747600)
3. Durakovic N, Bezak KB, Skarica M, et al: Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions. J Immunol 177:4414-4425, 2006 (Pubitemid 44469770)
4. Sackstein R: A revision of Billingham's tenets: The central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant 12:2-8, 2006 (suppl 1)
5. Waller EK, Rosenthal H, Jones TW, et al: Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 97:2948-2956, 2001
6. Heimfeld S: Bone marrow transplantation: How important is CD34 cell dose in HLA-identical stem cell transplantation? Leukemia 17:856-858, 2003
7. Przepiorka D, Weisdorf D, Martin P, et al: 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825-828, 1995
8. Anasetti C, Logan BR, Lee SJ, et al: Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 367:1487-1496, 2012
9. Olweus J, BitMansour A, Warnke R, et al: Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 94:12551-12556, 1997
10. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289-300, 1995
11. Storey JD: A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol 64:479-498, 2002
12. Hadeiba H, Sato T, Habtezion A, et al: CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 9:1253-1260, 2008
13. Rutella S, Danese S, Leone G: Tolerogenic dendritic cells: Cytokine modulation comes of age. Blood 108:1435-1440, 2006 (Pubitemid 44316106)
14. Banovic T, Markey KA, Kuns RD, et al: Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J Immunol 182:912-920, 2009
15. Wendland M, Czeloth N, Mach N, et al: CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Natl Acad Sci U S A 104:6347-6352, 2007 (Pubitemid 47186097)
16. Kolb HJ, Mittermüller J, Clemm C, et al: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465, 1990
17. Li JM, Southerland LT, Lu Y, et al: Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation. J Immunol 183:7799-7809, 2009
18. Lu Y, Giver CR, Sharma A, et al: IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood 119:1075-1085, 2012
19. Cardenas PA, Huang Y, Ildstad ST: The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. Chimerism 2:65-70, 2011
20. Leventhal J, Abecassis M, Miller J, et al: Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: Durable chimerism predicts outcome. Transplantation 95:169-176, 2013
21. King NJ, Thomas SR: Molecules in focus: Indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 39:2167-2172, 2007 (Pubitemid 47484274)
22. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, et al: Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality. Blood 111:3257-3265, 2008
23. Sela U, Olds P, Park A, et al: Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med 208:2489-2496, 2011
24. Colonna M, Trinchieri G, Liu YJ: Plasmacytoid dendritic cells in immunity. Nat Immunol 5:1219-1226, 2004 (Pubitemid 41057736)
25. Anderson BE, Taylor PA, McNiff JM, et al: Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naïve and memory phenotype CD4 T cells. Blood 111:5242-5251, 2008
26. Chen BJ, Cui X, Sempowski GD, et al: Transfer of allogeneic CD62L - memory T cells without graft-versus-host disease. Blood 103:1534-1541, 2004 (Pubitemid 38168675)
27. Giver CR, Li JM, Hossain MS, et al: Reconstructing immunity after allogeneic transplantation. Immunol Res 29:269-282, 2004 (Pubitemid 38822415)
28. Seok J, Warren HS, Cuenca AG, et al: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110:3507-3512, 2013
29. Shay T, Jojic V, Zuk O, et al: Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A 110:2946-2951, 2013
30. Mestas J, Hughes CC: Of mice and not men: Differences between mouse and human immunology. J Immunol 172:2731-2738, 2004 (Pubitemid 38263654)
31. Zeng D, Hoffmann P, Lan F, et al: Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: Impact on allogeneic bone marrow transplantation. Blood 99:1449-1457, 2002 (Pubitemid 34547104)